Back to Search
Start Over
Identification of a small and lethal subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib by MET amplification
- Source :
- Journal of Clinical Oncology. 29:4130-4130
- Publication Year :
- 2011
- Publisher :
- American Society of Clinical Oncology (ASCO), 2011.
-
Abstract
- 4130 Background: Amplification of the MET proto-oncogene in gastroesophageal cancer (GEC) may constitute a molecular marker for targeted therapy. We examined a GEC cohort with follow-up and report ...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Crizotinib
business.industry
medicine.medical_treatment
Met amplification
medicine.disease
Targeted therapy
chemistry.chemical_compound
Gastroesophageal cancer
chemistry
Internal medicine
Molecular marker
Cohort
Immunology
Medicine
Adenocarcinoma
Identification (biology)
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........755ed5a2a73d192325b2fa801bb2eec2
- Full Text :
- https://doi.org/10.1200/jco.2011.29.15_suppl.4130